293 related articles for article (PubMed ID: 2412863)
21. Expression of oncogenes in human hepatoma cell lines.
Ting LP; Jeng KS; Chou CK; Su TS; Hu CP; Wong FH; Chang HK; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):141-50. PubMed ID: 2854043
[TBL] [Abstract][Full Text] [Related]
22. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
[TBL] [Abstract][Full Text] [Related]
23. Proto-oncogene expression in proliferating and differentiating cardiac and skeletal muscle.
Claycomb WC; Lanson NA
Biochem J; 1987 Nov; 247(3):701-6. PubMed ID: 2447874
[TBL] [Abstract][Full Text] [Related]
24. Reversible interconversion between primitive endoderm- and parietal endoderm-like F9 cells demonstrated by mRNAs expression.
Miki K; Sugimoto E; Kitagawa Y
J Biochem; 1987 Aug; 102(2):385-92. PubMed ID: 2822687
[TBL] [Abstract][Full Text] [Related]
25. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
[TBL] [Abstract][Full Text] [Related]
26. Similarities and differences in the regulation of N-myc and c-myc genes in murine embryonal carcinoma cells.
Sejersen T; Rahm M; Szabo G; Ingvarsson S; Sümegi J
Exp Cell Res; 1987 Oct; 172(2):304-17. PubMed ID: 3308495
[TBL] [Abstract][Full Text] [Related]
27. Gene expression in visceral endoderm: a comparison of mutant and wild-type F9 embryonal carcinoma cell differentiation.
Rogers MB; Watkins SC; Gudas LJ
J Cell Biol; 1990 May; 110(5):1767-77. PubMed ID: 1692330
[TBL] [Abstract][Full Text] [Related]
28. Possible role of c-fos, c-N-ras and c-mos proto-oncogenes in muscular development.
Leibovitch MP; Leibovitch SA; Hillion J; Guillier M; Schmitz A; Harel J
Exp Cell Res; 1987 May; 170(1):80-92. PubMed ID: 3569436
[TBL] [Abstract][Full Text] [Related]
29. The relationship between embryonic, embryonal carcinoma and embryo-derived stem cells.
Rossant J; Papaioannou VE
Cell Differ; 1984 Dec; 15(2-4):155-61. PubMed ID: 6399008
[TBL] [Abstract][Full Text] [Related]
30. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
31. Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts.
Chen Y; Du Z; Yao Z
Cell Res; 2006 Jul; 16(7):641-50. PubMed ID: 16773043
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line.
Scott RW; Vogt TF; Croke ME; Tilghman SM
Nature; 1984 Aug 16-22; 310(5978):562-7. PubMed ID: 6205280
[TBL] [Abstract][Full Text] [Related]
33. Expression of the proto-oncogenes C-H-ras and N-ras in early second trimester human fetal tissues.
Mellersh H; Strain AJ; Hill DJ
Biochem Biophys Res Commun; 1986 Dec; 141(2):510-6. PubMed ID: 3541935
[TBL] [Abstract][Full Text] [Related]
34. A teratocarcinoma-derived endoderm stem cell line (1H5) that can differentiate into extra-embryonic endoderm cell types.
Adamson ED; Strickland S; Tu M; Kahan B
Differentiation; 1985; 29(1):68-76. PubMed ID: 2991056
[TBL] [Abstract][Full Text] [Related]
35. Constitutive c-myc expression enhances proliferation of differentiating F9 teratocarcinoma cells.
Schulz WA; Gais G
Biochim Biophys Acta; 1989 Sep; 1013(2):125-32. PubMed ID: 2475175
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of cellular oncogenes during rat liver development.
Zhang XK; Wang Z; Lee A; Huang DP; Chiu JF
Cancer Lett; 1988 Aug; 41(2):147-55. PubMed ID: 2456853
[TBL] [Abstract][Full Text] [Related]
37. Immortalization of early embryonic cell derivatives after the transfer of the early region of simian virus 40 into F9 teratocarcinoma cells.
Kellermann O; Kelly F
Differentiation; 1986; 32(1):74-81. PubMed ID: 3023162
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
39. Expression of c-mos proto-oncogene in undifferentiated teratocarcinoma cells.
Ogiso Y; Matsumoto M; Morita T; Nishino H; Iwashima A; Matsushiro A
Biochem Biophys Res Commun; 1986 Oct; 140(2):477-84. PubMed ID: 3778463
[TBL] [Abstract][Full Text] [Related]
40. Isolation of complementary DNA clones for genes exhibiting reduced expression after treatment of mouse teratocarcinoma stem cells with a tumor-promoting phorbol ester.
Miyata A; Akagi J; Fukuda M; Setoyama C; Shimada K; Akagi M
J Natl Cancer Inst; 1987 Oct; 79(4):881-90. PubMed ID: 2821315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
